Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,296.00Prev. Close
1,288.90Volume
1,06,443Total traded value
13.53 CrUpper Circuit
1,525.40Lower Circuit
1,017.00Fundamentals
| Market Cap | ₹32,276Cr |
| ROE | 12.60% |
| P/E Ratio(TTM) | 39.41 |
| EPS(TTM) | 32.28 |
| P/B Ratio | 4.65 |
| Dividend Yield | 0.31% |
| Industry P/E | 34.63 |
| Book Value | 273.88 |
| Debt to Equity | 0.20 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Ipca Laboratories
Ipca Laboratories is an integrated pharmaceutical company that manufactures and markets over 350 finished medicines and 80 active pharmaceutical ingredients (APIs). Its core philosophy is to contribute to global health and wellness by operating with the highest ethical standards in all its business activities. The company's medicines are trusted worldwide, with products being exported to more than 100 countries across the globe.;
| Parent Organisation | Ipca Laboratories |
| Managing Director | Mr. Pranay Godha |
| NSE Symbol | IPCALAB |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.00 | ||
| Cipla | NA (0.00%) | 22.32 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 17.42 | ||
| Mankind Pharma | NA (0.00%) | 51.41 |